• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用户对中低收入国家非侵入性和微创血糖自我监测设备的需求:吉尔吉斯斯坦、马里、秘鲁和坦桑尼亚的定性研究。

User requirements for non-invasive and minimally invasive glucose self-monitoring devices in low-income and middle-income countries: a qualitative study in Kyrgyzstan, Mali, Peru and Tanzania.

机构信息

Foundation for Innovative New Diagnostics, Geneva, Switzerland

Division of Tropical and Humanitarian Medicine, University of Geneva, Geneva, Switzerland.

出版信息

BMJ Open. 2024 Feb 17;14(2):e076685. doi: 10.1136/bmjopen-2023-076685.

DOI:10.1136/bmjopen-2023-076685
PMID:38367964
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10875487/
Abstract

AIMS

Development of non-invasive and minimally invasive glucose monitoring devices (NI-MI-GMDs) generally takes place in high-income countries (HICs), with HIC's attributes guiding product characteristics. However, people living with diabetes (PLWD) in low-income and middle-income countries (LMICs) encounter different challenges to those in HICs. This study aimed to define requirements for NI-MI-GMDs in LMICs to inform a target product profile to guide development and selection of suitable devices.

METHODS

This was a multiple-methods, exploratory, qualitative study conducted in Kyrgyzstan, Mali, Peru and Tanzania. Interviews and group discussions/activities were conducted with healthcare workers (HCWs), adults living with type 1 (PLWD1) or type 2 diabetes (PLWD2), adolescents living with diabetes and caregivers.

RESULTS

Among 383 informants (90 HCW, 100 PLWD1, 92 PLWD2, 24 adolescents, 77 caregivers), a range of differing user requirements were reported, including preferences for area of glucose measurement, device attachment, data display, alert type and temperature sensitivity. Willingness to pay varied across countries; common requirements included ease of use, a range of guiding functions, the possibility to attach to a body part of choice and a cost lower than or equal to current glucose self-monitoring.

CONCLUSIONS

Ease-of-use and affordability were consistently prioritised, with broad functionality required for alarms, measurements and attachment possibilities. Perspectives of PLWD are crucial in developing a target product profile to inform characteristics of NI-MI-GMDs in LMICs. Stakeholders must consider these requirements to guide development and selection of NI-MI-GMDs at country level, so that devices are fit for purpose and encourage frequent glucose monitoring among PLWD in these settings.

摘要

目的

非侵入性和微创血糖监测设备(NI-MI-GMD)的开发通常在高收入国家(HIC)进行,HIC 的属性指导产品特征。然而,中低收入国家(LMIC)的糖尿病患者(PLWD)面临的挑战与 HIC 不同。本研究旨在确定 LMIC 对 NI-MI-GMD 的要求,以提供目标产品概况,指导设备的开发和选择。

方法

这是一项在吉尔吉斯斯坦、马里、秘鲁和坦桑尼亚进行的多方法、探索性、定性研究。与卫生保健工作者(HCW)、1 型(PLWD1)或 2 型糖尿病(PLWD2)患者、患有糖尿病的青少年和照顾者进行了访谈和小组讨论/活动。

结果

在 383 名受访者(90 名 HCW、100 名 PLWD1、92 名 PLWD2、24 名青少年、77 名照顾者)中,报告了一系列不同的用户需求,包括对血糖测量区域、设备附件、数据显示、报警类型和温度敏感性的偏好。不同国家的支付意愿有所不同;常见的要求包括易于使用、广泛的引导功能、可附在身体选择部位的可能性以及低于或等于当前血糖自我监测的成本。

结论

易用性和负担能力一直是优先考虑的,报警、测量和附件的广泛功能是必需的。PLWD 的观点对于开发目标产品概况以告知 LMIC 中的 NI-MI-GMD 特征至关重要。利益相关者必须考虑这些要求,以指导国家一级的 NI-MI-GMD 开发和选择,使设备能够满足目的,并鼓励这些环境中的 PLWD 经常进行血糖监测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/026e/10875487/2bf70f332b85/bmjopen-2023-076685f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/026e/10875487/48ae3acd25ba/bmjopen-2023-076685f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/026e/10875487/2bf70f332b85/bmjopen-2023-076685f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/026e/10875487/48ae3acd25ba/bmjopen-2023-076685f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/026e/10875487/2bf70f332b85/bmjopen-2023-076685f02.jpg

相似文献

1
User requirements for non-invasive and minimally invasive glucose self-monitoring devices in low-income and middle-income countries: a qualitative study in Kyrgyzstan, Mali, Peru and Tanzania.用户对中低收入国家非侵入性和微创血糖自我监测设备的需求:吉尔吉斯斯坦、马里、秘鲁和坦桑尼亚的定性研究。
BMJ Open. 2024 Feb 17;14(2):e076685. doi: 10.1136/bmjopen-2023-076685.
2
Management of type 1 diabetes in low- and middle-income countries: Comparative health system assessments in Kyrgyzstan, Mali, Peru and Tanzania.低收入和中等收入国家1型糖尿病的管理:吉尔吉斯斯坦、马里、秘鲁和坦桑尼亚的卫生系统比较评估
Diabet Med. 2022 Aug;39(8):e14891. doi: 10.1111/dme.14891. Epub 2022 Jun 6.
3
Availability, prices and affordability of self-monitoring blood glucose devices: surveys in six low-income and middle-income countries.自我监测血糖设备的可及性、价格及可负担性:六个低收入和中等收入国家的调查
BMJ Public Health. 2025 Feb 22;3(1):e001128. doi: 10.1136/bmjph-2024-001128. eCollection 2025 Jan.
4
Development of a target product profile for new glucose self-monitoring technologies for use in low- and middle-income countries.为在中低收入国家使用的新型葡萄糖自我监测技术制定目标产品特性。
PLoS One. 2024 Aug 26;19(8):e0309062. doi: 10.1371/journal.pone.0309062. eCollection 2024.
5
Diabetes risk and provision of diabetes prevention activities in 44 low-income and middle-income countries: a cross-sectional analysis of nationally representative, individual-level survey data.44 个低收入和中等收入国家的糖尿病风险和糖尿病预防活动提供情况:基于全国代表性、个人层面调查数据的横断面分析。
Lancet Glob Health. 2023 Oct;11(10):e1576-e1586. doi: 10.1016/S2214-109X(23)00348-0.
6
Adherence to self-care behaviours and associated barriers in type 2 diabetes patients of low-and middle-income countries: a systematic review protocol.低收入和中等收入国家2型糖尿病患者自我护理行为的依从性及相关障碍:一项系统评价方案
Syst Rev. 2017 Feb 27;6(1):39. doi: 10.1186/s13643-017-0436-4.
7
The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults.44 个低收入和中等收入国家的高血压护理状况:来自 110 万成年人的全国代表性个体水平数据的横断面研究。
Lancet. 2019 Aug 24;394(10199):652-662. doi: 10.1016/S0140-6736(19)30955-9. Epub 2019 Jul 18.
8
Point-of-care biochemistry for primary healthcare in low-middle income countries: a qualitative inquiry.中低收入国家基层医疗中的即时床旁生化检验:一项定性研究。
BMC Prim Care. 2024 Oct 11;25(1):362. doi: 10.1186/s12875-024-02604-0.
9
Evaluation of self-care practices and emotional distress among people with Type 2 diabetes mellitus in Dar es Salaam, Tanzania.坦桑尼亚达累斯萨拉姆2型糖尿病患者自我护理行为及情绪困扰的评估
Ecol Food Nutr. 2009 Mar-Apr;48(2):89-111. doi: 10.1080/03670240802577457.
10
Development of the 'REadiness SElf-assessment (RESEA) guide' to assist low and middle-income countries with establishing safe and sustainable radiotherapy services: a pragmatic sequential mixed qualitative methods project.制定“准备情况自我评估(RESEA)指南”以协助低收入和中等收入国家建立安全且可持续的放射治疗服务:一项务实的序贯混合定性方法项目
BMC Health Serv Res. 2021 Mar 23;21(1):268. doi: 10.1186/s12913-021-06274-x.

引用本文的文献

1
Adapting and Accepting Type 1 Diabetes: A Qualitative Exploration of the Perspectives from People with Type 1 Diabetes from 13 Countries.适应与接受1型糖尿病:对来自13个国家的1型糖尿病患者观点的定性探索
Healthcare (Basel). 2025 Jun 9;13(12):1380. doi: 10.3390/healthcare13121380.
2
Development of a target product profile for new glucose self-monitoring technologies for use in low- and middle-income countries.为在中低收入国家使用的新型葡萄糖自我监测技术制定目标产品特性。
PLoS One. 2024 Aug 26;19(8):e0309062. doi: 10.1371/journal.pone.0309062. eCollection 2024.

本文引用的文献

1
Diabetes patient preferences for glucose-monitoring technologies: results from a discrete choice experiment in Poland and the Netherlands.糖尿病患者对血糖监测技术的偏好:来自波兰和荷兰的离散选择实验结果。
BMJ Open Diabetes Res Care. 2023 Jan;11(1). doi: 10.1136/bmjdrc-2022-003025.
2
Management of type 1 diabetes in low- and middle-income countries: Comparative health system assessments in Kyrgyzstan, Mali, Peru and Tanzania.低收入和中等收入国家1型糖尿病的管理:吉尔吉斯斯坦、马里、秘鲁和坦桑尼亚的卫生系统比较评估
Diabet Med. 2022 Aug;39(8):e14891. doi: 10.1111/dme.14891. Epub 2022 Jun 6.
3
A framework for designing medical devices resilient to low-resource settings.
设计医疗器械的框架,使其能够在资源匮乏的环境中具有弹性。
Global Health. 2021 Jun 22;17(1):64. doi: 10.1186/s12992-021-00718-z.
4
Products for Monitoring Glucose Levels in the Human Body With Noninvasive Optical, Noninvasive Fluid Sampling, or Minimally Invasive Technologies.用于人体无创光学、非侵入式流体采样或微创技术监测血糖水平的产品。
J Diabetes Sci Technol. 2022 Jan;16(1):168-214. doi: 10.1177/19322968211007212. Epub 2021 Jun 13.
5
Technologies for Diabetes Self-Monitoring: A Scoping Review and Assessment Using the REASSURED Criteria.糖尿病自我监测技术:使用 REASSURED 标准进行的范围综述和评估。
J Diabetes Sci Technol. 2022 Jul;16(4):962-970. doi: 10.1177/1932296821997909. Epub 2021 Mar 9.
6
The Challenges in the Development of Diabetes Prevention and Care Models in Low-Income Settings.低收入国家发展糖尿病预防和照护模式面临的挑战。
Front Endocrinol (Lausanne). 2020 Aug 13;11:518. doi: 10.3389/fendo.2020.00518. eCollection 2020.
7
Medical Devices for Low- and Middle-Income Countries: A Review and Directions for Development.面向低收入和中等收入国家的医疗设备:综述与发展方向
J Med Device. 2020 Mar 1;14(1):010803. doi: 10.1115/1.4045910. Epub 2020 Feb 5.
8
Target Product Profile for a mobile app to read rapid diagnostic tests to strengthen infectious disease surveillance.用于读取快速诊断检测结果以加强传染病监测的移动应用程序的目标产品概况。
PLoS One. 2020 Jan 29;15(1):e0228311. doi: 10.1371/journal.pone.0228311. eCollection 2020.
9
Determinants of poor glycemic control among adult patients with type 2 diabetes mellitus in Jimma University Medical Center, Jimma zone, south west Ethiopia: a case control study.埃塞俄比亚西南部 Jimma 地区 Jimma 大学医学中心的 2 型糖尿病成年患者血糖控制不佳的决定因素:一项病例对照研究。
BMC Endocr Disord. 2019 Aug 29;19(1):91. doi: 10.1186/s12902-019-0421-0.
10
The Progress of Glucose Monitoring-A Review of Invasive to Minimally and Non-Invasive Techniques, Devices and Sensors.葡萄糖监测的进展——侵入性到微创和非侵入性技术、设备和传感器的综述。
Sensors (Basel). 2019 Feb 15;19(4):800. doi: 10.3390/s19040800.